Kenji Murano

508 total citations
12 papers, 415 citations indexed

About

Kenji Murano is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Kenji Murano has authored 12 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Infectious Diseases and 3 papers in Organic Chemistry. Recurrent topics in Kenji Murano's work include PARP inhibition in cancer therapy (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Chemical Synthesis and Analysis (2 papers). Kenji Murano is often cited by papers focused on PARP inhibition in cancer therapy (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Chemical Synthesis and Analysis (2 papers). Kenji Murano collaborates with scholars based in Japan and United States. Kenji Murano's co-authors include Kouji Hattori, Kazunori Kamijo, Hiroshi Miyake, Junya Ishida, Akinori Iwashita, Nobuya Matsuoka, Mitsuru Ohkubo, Hirofumi Yamamoto, Yoshiyuki Kido and Takayoshi Kinoshita and has published in prestigious journals such as Chemical Communications, FEBS Letters and Journal of Medicinal Chemistry.

In The Last Decade

Kenji Murano

12 papers receiving 403 citations

Peers

Countries citing papers authored by Kenji Murano

Since Specialization

Citations

This map shows the geographic impact of Kenji Murano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Murano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Murano more than expected).

Fields of papers citing papers by Kenji Murano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Murano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Murano. The network helps show where Kenji Murano may publish in the future.

Co-authorship network of co-authors of Kenji Murano

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Murano. A scholar is included among the top collaborators of Kenji Murano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Murano. Kenji Murano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Identification of novel plasminogen activator inhibitor-1 inhibitors with improved oral bioavailability: Structure optimization of N-acylanthranilic acid derivatives 2018 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Kenji Murano, Hidehiko Kodama, Akihisa Maeda, Takashi Dan, Tetsuo Nakabayashi, Toshio Miyata, Kanji Meguro	14
2	Flavin-catalyzed aerobic oxidation of sulfides and thiols with formic acid/triethylamine 2014 ·Chemical Communications ·Shun‐Ichi Murahashi, Dazhi Zhang, Hiroki Iida, (unknown), (unknown), Kenji Murano, Kanji Meguro	54
3	Synthesis and SAR of novel parenteral anti-pseudomonal cephalosporins: Discovery of FR264205 2008 ·Bioorganic & Medicinal Chemistry Letters ·Ayako Toda, Hidenori Ohki, Toshio Yamanaka, Kenji Murano, Shinya Okuda, Kohji Kawabata, Kazuo Hatano, Keiji Matsuda, (unknown), Kenji Itoh, (unknown), Satoshi Inoue	44
4	Structural requirements for the stability of novel cephalosporins to AmpC β-lactamase based on 3D-structure 2007 ·Bioorganic & Medicinal Chemistry ·Kenji Murano, Toshio Yamanaka, Ayako Toda, Hidenori Ohki, Shinya Okuda, Kohji Kawabata, Kazuo Hatano, Shinobu Takeda, (unknown), Kenji Itoh, (unknown), Satoshi Inoue, Tatsuya Takagi	37
5	Discovery of quinazolinone and quinoxaline derivatives as potent and selective poly(ADP‐ribose) polymerase‐1/2 inhibitors 2005 ·FEBS Letters ·Akinori Iwashita, Kouji Hattori, Hirofumi Yamamoto, Junya Ishida, Yoshiyuki Kido, Kazunori Kamijo, Kenji Murano, Hiroshi Miyake, Takayoshi Kinoshita, Masaichi Warizaya, Mitsuru Ohkubo, Nobuya Matsuoka, Seitaro Mutoh	65
6	Discovery of potent and selective PARP-1 and PARP-2 inhibitors: SBDD analysis via a combination of X-ray structural study and homology modeling 2005 ·Bioorganic & Medicinal Chemistry ·Junya Ishida, Hirofumi Yamamoto, Yoshiyuki Kido, Kazunori Kamijo, Kenji Murano, Hiroshi Miyake, Mitsuru Ohkubo, Takayoshi Kinoshita, Masaichi Warizaya, Akinori Iwashita, Kayoko Mihara, Nobuya Matsuoka, Kouji Hattori	66
7	Rational Approaches to Discovery of Orally Active and Brain-Penetrable Quinazolinone Inhibitors of Poly(ADP-ribose)polymerase 2004 ·Journal of Medicinal Chemistry ·Kouji Hattori, Yoshiyuki Kido, Hirofumi Yamamoto, Junya Ishida, Kazunori Kamijo, Kenji Murano, Mitsuru Ohkubo, Takayoshi Kinoshita, Akinori Iwashita, Kayoko Mihara, (unknown), Nobuya Matsuoka, Yoshinori TERAMURA, Hiroshi Miyake	80
8	Conformational studies on the four stereoisomers of the novel anticholinergic 4-(dimethylamino)-2-phenyl-2-(2-pyridyl)pentanamide 1995 ·Journal of Computer-Aided Molecular Design ·(unknown), Isao Nakanishi, Akito Tanaka, Kenji Murano, Masaaki Matsuo	2
9	CS-045, a new oral antidiabetic agent, stimulates fructose-2,6-bisphosphate production in rat hepatocytes 1994 ·European Journal of Pharmacology ·Kenji Murano, Yasushi Inoue, Masahiro Emoto, Kohei Kaku, Toshio Kaneko	21
10	Studies on neurokinin antagonists. 3. Design and structure-activity relationships of new branched tripeptides N.alpha.-(substituted L-aspartyl, L-ornithyl, or L-lysyl)-N-methyl-N-(phenylmethyl)-L-phenylalaninamides as substance P antagonists 1993 ·Journal of Medicinal Chemistry ·Daijiro Hagiwara, Hiroshi Miyake, Kenji Murano, Hiroshi Morimoto, Masako Murai, Takashi Fujii, Isao Nakanishi, Masaaki Matsuo	11
11	Design of a novel dipeptide substance P antagonist FK888 1993 ·Regulatory Peptides ·Daijiro Hagiwara, Hiroshi Miyake, (unknown), Kenji Murano, Hiroshi Morimoto, Masako Murai, Takashi Fujii, Masaaki Matsuo	9
12	Asymmetric synthesis using chiral acetals: Highly stereoselective reduction of chiral .ALPHA.-keto-.BETA.,.GAMMA.-unsaturated acetals and its application for the synthese of (R)-(-)- and (S)-(+)-3'-methoxy-4'-O-methyljoubertiamine. 1989 ·Chemical and Pharmaceutical Bulletin ·Hiromichi Fujioka, Hirokazu Annoura, Kenji Murano, Yasuyuki Kita, Yasumitsu Tamura	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact